FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bo Lu

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Tumor Cell Line

Physiology

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Nicholas J Giacalone; Pierre P Massion; Sandra J Olson; David P Carbone; Heidi Chen; Robert B Den; Rosana Eisenberg; Bo Lu
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma.
Bo Li; Adam P Dicker; Ruihong Du; Yunguang Sun; Artour Torossian; Bo Lu
Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
Natalie L Ausborn; Jeffrey D Bradley; Hak Choy; Adam P Dicker; Quynh-Thu Le; Debabrata Saha; Jeff Simko; Michael D Story; Artour Torossian; Bo Lu
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bo Lu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nicholas J Giacalone; Pierre P Massion; Sandra J Olson; David P Carbone; Heidi Chen; Robert B Den; Rosana Eisenberg; Bo Lu
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma.
Future oncology (London, England) 2013;9(5):737-45.
2012: Bo Li; Adam P Dicker; Ruihong Du; Yunguang Sun; Artour Torossian; Bo Lu
Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
International journal of radiation oncology, biology, physics 2012;84(4):e525-31.
2012: Natalie L Ausborn; Jeffrey D Bradley; Hak Choy; Adam P Dicker; Quynh-Thu Le; Debabrata Saha; Jeff Simko; Michael D Story; Artour Torossian; Bo Lu
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
International journal of radiation oncology, biology, physics 2012;83(4):e453-64.
2012: Yunguang Sun; Artour Torossian; Zhongming Zhao; Siyuan Zheng; David P Carbone; Nicholas J Giacalone; Stephen Schleicher; Christina K Speirs; Bo Lu
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.
International journal of radiation oncology, biology, physics 2012;82(3):e563-72.
2011: Bo Li; Wenyan Li; Heidi Chen; Nicholas J Giacalone; Adriana Gonzalez; Sung June Kim; Luigi Moretti; Kathy Niu; Stephen Schleicher; Artour Torossian; Bo Lu
A novel bioluminescence orthotopic mouse model for advanced lung cancer.
Radiation research 2011;176(4):486-93.
2011: Kwang Woon Kim; Dae Kwang Jung; Christina K Speirs; Bo Lu
The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1542-52.
2011: Luigi Moretti; Kenneth J Niermann; Stephen Schleicher; Vinod Varki; Nicholas J Giacalone; Dae Kwang Jung; Kwang Woon Kim; Prapaporn Kopsombut; Bo Lu
MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
International journal of radiation oncology, biology, physics 2011;80(4):1189-97.
2011: Jerry Jaboin; Misun Hwang; Carmen A Perez; Calvin Cooper; Heidi Chen; Chuanzhong Ye; Qiuyin Cai; Marcia L Wills; Bo Lu
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
Urologic oncology 2011;29(3):319-23.
2011: Yunguang Sun; Luigi Moretti; Nicholas J Giacalone; Stephen Schleicher; Christina K Speirs; David P Carbone; Bo Lu
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(4):699-706.
2011: Kenneth J Niermann; Luigi Moretti; Nicholas J Giacalone; Yunguang Sun; Stephen M Schleicher; Prapaporn Kopsombut; Lauren R Mitchell; Kwang Woon Kim; Bo Lu
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.
Radiation research 2011;175(4):444-51.
2011: Jerry Jaboin; Misun Hwang; Zachary Lopater; Heidi Chen; Geoffrey L Ray; Carmen Perez; Qiuyin Cai; Marcia L Wills; Bo Lu
The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2011;79(5):1330-5.
2011: Bo Lu; Shih-Hwa Chiou; Eric Deutsch; Aurelio Lorico
Cancer stem cells.
Journal of oncology 2011;2011():269437.
2011: Yunguang Sun; Nicholas J Giacalone; Bo Lu
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):8-14.
2010: Christopher Willey; Dakai Xiao; Tianxiang Tu; Kwang Woon Kim; Luigi Moretti; Kenneth J Niermann; Mohammed N Tawtawy; Chad C Quarles; Bo Lu
Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.
International journal of radiation oncology, biology, physics 2010;77(5):1518-26.
2010: Kwang Woon Kim; Luigi Moretti; L R Mitchell; D K Jung; Bo Lu
Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells.
Oncogene 2010;29(22):3241-51.
2010: Stephen M Schleicher; Luigi Moretti; Vinod Varki; Bo Lu
Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2010;13(3):79-86.
2010: Luigi Moretti; Bo Li; Kwang Woon Kim; Heidi Chen; Bo Lu
AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(5):680-7.
2010: Carmen A Perez; Heidi Chen; Yu Shyr; Regina Courtney; Wei Zheng; Qiuyin Cai; Misun Hwang; Jerry Jaboin; Stephen Schleicher; Luigi Moretti; Marcia Wills; Joseph A Smith; Bo Lu
The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
The Journal of urology 2010;183(5):2062-9.
2010: Daniel E Spratt; Roberto Diaz; James McElmurray; Ildiko Csiki; Dennis Duggan; Bo Lu; Dominique Delbeke
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Clinical nuclear medicine 2010;35(4):237-43.
2009: Luigi Moretti; David S Yu; Heidi Chen; David P Carbone; David H Johnson; Vicki L Keedy; Joe B Putnam; Alan B Sandler; Yu Shyr; Bo Lu
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
The oncologist 2009;14(11):1106-15.
2009: Kwang Woon Kim; Luigi Moretti; Lauren Rhea Mitchell; Dae Kwang Jung; Bo Lu
Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6096-105.
2009: Nidhish Sasi; Misun Hwang; Jerry Jaboin; Ildiko Csiki; Bo Lu
Regulated cell death pathways: new twists in modulation of BCL2 family function.
Molecular cancer therapeutics 2009;8(6):1421-9.
2009: Lauren R Mitchell; Jeffrey M Albert; Bo Lu
Chemoradiotherapy in locally advanced, unresectable non-small cell lung cancer.
Reviews on recent clinical trials 2009;4(2):110-21.
2009: Luigi Moretti; Kwang Woon Kim; Dae Kwang Jung; Christopher D Willey; Bo Lu
Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor.
Molecular cancer therapeutics 2009;8(5):1270-9.
2009: Misun Hwang; Luigi Moretti; Bo Lu
HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy.
Current medicinal chemistry 2009;16(24):3081-92.
2009: Jerry Jaboin; Misun Hwang; Bo Lu
Autophagy in lung cancer.
Methods in enzymology 2009;453():287-304.
2009: Jun Qian; Yong Zou; Jamshedur S M Rahman; Bo Lu; Pierre P Massion
Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung.
Molecular cancer therapeutics 2009;8(1):101-9.
2008: Kwang Woon Kim; Misun Hwang; Luigi Moretti; Jerry Jaboin; yong cha; Bo Lu
Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer.
Autophagy 2008;4(5):659-68.
2008: Kwang Woon Kim; Luigi Moretti; Bo Lu
M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models.
PloS one 2008;3(5):e2275.
2007: Jerry Jaboin; Eric T Shinohara; Luigi Moretti; Eddy Yang; Joseph M Kaminski; Bo Lu
The role of mTOR inhibition in augmenting radiation induced autophagy.
Technology in cancer research & treatment 2007;6(5):443-7.
2007: Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Zebrafish as a model system to screen radiation modifiers.
Current genomics 2007;8(6):360-9.
2007: Jeffrey M Albert; Adriana Gonzalez; Pierre P Massion; Heidi Chen; Sandra J Olson; Yu Shyr; Roberto Diaz; Eric S Lambright; Alan B Sandler; David P Carbone; Joe B Putnam; David H Johnson; Bo Lu
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(9):1845-51.
2007: Luigi Moretti; Eddy Yang; Kwang W Kim; Bo Lu
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(4-5):135-43.
2007: George X Ding; Dennis M Duggan; Bo Lu; Dennis E Hallahan; Anthony J Cmelak; Arnold Malcolm; Jared Newton; Matthew Deeley; Charles W Coffey
Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy.
Medical physics 2007;34(7):2985-94.
2007: Jeffrey M Albert; Carolyn Cao; Kwang Woon Kim; Christopher Willey; Ling Geng; Dakai Xiao; Hong Wang; Alan B Sandler; David H Johnson; Alexander D Colevas; Jennifer Low; Mace L Rothenberg; Bo Lu
Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):3033-42.
2007: Kwang Woon Kim; Robert W Mutter; Christopher Willey; Ty K Subhawong; Eric T Shinohara; Jeffrey M Albert; Geng Ling; Carolyn Cao; Young Jin Gi; Bo Lu
Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.
International journal of radiation oncology, biology, physics 2007;67(5):1519-25.
2007: Luigi Moretti; yong cha; Kenneth John Niermann; Bo Lu
Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress?
Cell cycle (Georgetown, Tex.) 2007;6(7):793-8.
2007: Dennis M Duggan; George X Ding; Charles W Coffey; Wyndee Kirby; Dennis E Hallahan; Arnold Malcolm; Bo Lu
Deep-inspiration breath-hold kilovoltage cone-beam CT for setup of stereotactic body radiation therapy for lung tumors: initial experience.
Lung cancer (Amsterdam, Netherlands) 2007;56(1):77-88.
2007: Luigi Moretti; Albert Attia; Kwang Woon Kim; Bo Lu
Crosstalk between Bak/Bax and mTOR signaling regulates radiation-induced autophagy.
Autophagy 2007;3(2):142-4.
2007: Eric T Shinohara; Adriana Gonzalez; Pierre P Massion; Sandra J Olson; Jeffrey M Albert; Yu Shyr; David P Carbone; David H Johnson; Dennis E Hallahan; Bo Lu
PDGFR-beta expression in small cell lung cancer patients.
International journal of radiation oncology, biology, physics 2007;67(2):431-7.
2006: Carolyn Cao; Jeffrey M Albert; Ling Geng; Percy S Ivy; Alan B Sandler; David H Johnson; Bo Lu
Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
Cancer research 2006;66(23):11409-15.
2006: Kwang Woon Kim; Robert W Mutter; Carolyn Cao; Jeffrey M Albert; Michael Freeman; Dennis E Hallahan; Bo Lu
Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling.
The Journal of biological chemistry 2006;281(48):36883-90.
2006: He-Cheng Li; Jeffrey M Albert; Eric T Shinohara; Qiuyin Cai; Andrea Freyer; Hui Cai; Carolyn Cao; Zuofei Wang; Nobuhiko Kataoka; Ming Teng; Wei Zheng; Bo Lu
E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.
Urologic oncology 2006;24(6):496-502.
2006: Kwang Woon Kim; Robert W Mutter; Carolyn Cao; Jeffrey M Albert; Eric T Shinohara; SEKHAR KONJETI; Bo Lu
Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation.
Molecular cancer therapeutics 2006;5(11):2659-65.
2006: Carolyn Cao; Ty K Subhawong; Jeffrey M Albert; Kwang Woon Kim; Ling Geng; SEKHAR KONJETI; Young Jin Gi; Bo Lu
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.
Cancer research 2006;66(20):10040-7.
2006: Jeffrey M Albert; Carolyn Cao; Ling Geng; Lauren Leavitt; Dennis E Hallahan; Bo Lu
Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
International journal of radiation oncology, biology, physics 2006;65(5):1536-43.
2006: Robert E Lee Browning; Hecheng Li; Eric T Shinohara; Qiuyin Cai; Heidi Chen; Regina Courtney; Carolyn Cao; Wei Zheng; Bo Lu
ATM polymorphism IVS62+60G>A is not associated with disease aggressiveness in prostate cancer.
Urology 2006;67(6):1320-3.
2006: Jeffrey M Albert; Kwang Woon Kim; Carolyn Cao; Bo Lu
Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer.
Molecular cancer therapeutics 2006;5(5):1183-9.
2006: Carolyn Cao; Eric T Shinohara; Ty K Subhawong; Ling Geng; Jeffrey M Albert; Dennis E Hallahan; Kwang Woon Kim; Bo Lu
Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2.
Molecular cancer therapeutics 2006;5(2):411-7.
2005: Bo Lu; Eric T Shinohara; Eric Edwards; Ling Geng; Jiahuai Tan; Dennis E Hallahan
The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy.
Technology in cancer research & treatment 2005;4(6):691-8.
2005: Carolyn Cao; Eric T Shinohara; Hecheng Li; Kenneth J Niermann; Kwang Woon Kim; SEKHAR KONJETI; Martin Gleave; Michael Freeman; Bo Lu
Clusterin as a therapeutic target for radiation sensitization in a lung cancer model.
International journal of radiation oncology, biology, physics 2005;63(4):1228-36.
2005: Eric T Shinohara; Carolyn Cao; Kenneth J Niermann; Yi Mu; Fenghua Zeng; Dennis E Hallahan; Bo Lu
Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
Oncogene 2005;24(35):5414-22.
2005: Carolyn Cao; Eric T Shinohara; Kenneth J Niermann; Edwin F Donnelly; Xinping Chen; Dennis E Hallahan; Bo Lu
Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer.
Molecular cancer therapeutics 2005;4(8):1137-45.
2005: Eric T Shinohara; Adriana Gonzalez; Pierre P Massion; Heidi Chen; Ming Li; Andrea S Freyer; Sandra J Olson; Jeremiah J Andersen; Yu Shyr; David P Carbone; David H Johnson; Dennis E Hallahan; Bo Lu
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
Cancer 2005;103(8):1685-92.
2004: Eric T Shinohara; Bo Lu; Dennis E Hallahan
The use of gene therapy in cancer research and treatment.
Technology in cancer research & treatment 2004;3(5):479-90.
2004: Carolyn Cao; Yi Mu; Dennis E Hallahan; Bo Lu
XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer.
Oncogene 2004;23(42):7047-52.
2004: Dong Wook Kim; Bo Lu; Dennis E Hallahan
Receptor tyrosine kinase inhibitors as anti-angiogenic agents.
Current opinion in investigational drugs (London, England : 2000) 2004;5(6):597-604.
2004: Bo Lu; Yi Mu; Carolyn Cao; Fenghua Zeng; Sylke Schneider; Jiahui Tan; Jim Price; Jun Chen; Michael Freeman; Dennis E Hallahan
Survivin as a therapeutic target for radiation sensitization in lung cancer.
Cancer research 2004;64(8):2840-5.
2004: Donnie R Stacy; Bo Lu; Dennis E Hallahan
Radiation-guided drug delivery systems.
Expert review of anticancer therapy 2004;4(2):283-8.
2004: Bo Lu; Ling Geng; Amy Musiek; Jiahui Tan; Carolyn Cao; Edwin F Donnelly; Gerald McMahon; Hak Choy; Dennis E Hallahan
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.
International journal of radiation oncology, biology, physics 2004;58(3):844-50.